Your browser doesn't support javascript.
loading
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial.
Shinde, Vivek; Cho, Iksung; Plested, Joyce S; Agrawal, Sapeckshita; Fiske, Jamie; Cai, Rongman; Zhou, Haixia; Pham, Xuan; Zhu, Mingzhu; Cloney-Clark, Shane; Wang, Nan; Zhou, Bin; Lewis, Maggie; Price-Abbott, Patty; Patel, Nita; Massare, Michael J; Smith, Gale; Keech, Cheryl; Fries, Louis; Glenn, Gregory M.
Afiliación
  • Shinde V; Novavax, Gaithersburg, MD, USA. Electronic address: vshinde@novavax.com.
  • Cho I; Novavax, Gaithersburg, MD, USA.
  • Plested JS; Novavax, Gaithersburg, MD, USA.
  • Agrawal S; Novavax, Gaithersburg, MD, USA; Assembly Biosciences, San Francisco, CA, USA.
  • Fiske J; Novavax, Gaithersburg, MD, USA.
  • Cai R; Novavax, Gaithersburg, MD, USA; Parexel, Billerica, MA, USA.
  • Zhou H; Novavax, Gaithersburg, MD, USA.
  • Pham X; Novavax, Gaithersburg, MD, USA; AstraZeneca Pharmaceuticals, Gaithersburg, MD, USA.
  • Zhu M; Novavax, Gaithersburg, MD, USA.
  • Cloney-Clark S; Novavax, Gaithersburg, MD, USA.
  • Wang N; Novavax, Gaithersburg, MD, USA.
  • Zhou B; Novavax, Gaithersburg, MD, USA.
  • Lewis M; Novavax, Gaithersburg, MD, USA.
  • Price-Abbott P; Novavax, Gaithersburg, MD, USA.
  • Patel N; Novavax, Gaithersburg, MD, USA.
  • Massare MJ; Novavax, Gaithersburg, MD, USA.
  • Smith G; Novavax, Gaithersburg, MD, USA.
  • Keech C; Novavax, Gaithersburg, MD, USA.
  • Fries L; Novavax, Gaithersburg, MD, USA.
  • Glenn GM; Novavax, Gaithersburg, MD, USA.
Lancet Infect Dis ; 22(1): 73-84, 2022 01.
Article en En | MEDLINE | ID: mdl-34563277

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Saponinas / Vacunas contra la Influenza / Gripe Humana / Nanopartículas / Inmunogenicidad Vacunal / Adyuvantes de Vacunas / Anticuerpos Antivirales Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Saponinas / Vacunas contra la Influenza / Gripe Humana / Nanopartículas / Inmunogenicidad Vacunal / Adyuvantes de Vacunas / Anticuerpos Antivirales Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos